No connection

Search Results

OPK vs SDGR

OPK
OPKO Health, Inc.
BEARISH
Price
$1.18
Market Cap
$905.9M
Sector
Healthcare
AI Confidence
85%
SDGR
Schrödinger, Inc.
BEARISH
Price
$12.34
Market Cap
$911.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
OPK
--
SDGR
--
Forward P/E
OPK
-3.58
SDGR
-8.94
P/B Ratio
OPK
0.71
SDGR
2.5
P/S Ratio
OPK
1.49
SDGR
3.56
EV/EBITDA
OPK
-7.29
SDGR
-3.88

Profitability

Gross Margin
OPK
13.5%
SDGR
55.74%
Operating Margin
OPK
-28.98%
SDGR
-19.67%
Profit Margin
OPK
-37.19%
SDGR
-40.36%
ROE
OPK
-17.14%
SDGR
-26.29%
ROA
OPK
-6.62%
SDGR
-13.46%

Growth

Revenue Growth
OPK
-19.2%
SDGR
-1.2%
Earnings Growth
OPK
--
SDGR
--

Financial Health

Debt/Equity
OPK
0.31
SDGR
0.3
Current Ratio
OPK
3.97
SDGR
2.75
Quick Ratio
OPK
3.21
SDGR
2.64

Dividends

Dividend Yield
OPK
--
SDGR
--
Payout Ratio
OPK
0.0%
SDGR
0.0%

AI Verdict

OPK BEARISH

OPK exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.97 and low debt, these are offset by a -19.2% decline in year-over-year revenue and deeply negative profit margins. The stock is trading below its book value (P/B 0.71), but the persistent long-term price decay (-72.8% over 5 years) suggests a value trap rather than a bargain. Despite optimistic analyst price targets, the deterministic data points to a company in structural decline.

Strengths
Strong short-term liquidity (Current Ratio 3.97)
Low leverage (Debt/Equity 0.31)
Trading at a discount to book value (P/B 0.71)
Risks
Severe operational weakness (Piotroski F-Score 1/9)
Significant revenue contraction (-19.2% YoY)
Deeply negative profit margins (-37.19%)
SDGR BEARISH

SDGR exhibits significant financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' category. Despite a strong liquidity position (Current Ratio 2.75) and low leverage (Debt/Equity 0.30), the company suffers from persistent negative profitability and stagnant revenue growth (-1.20% YoY). The severe long-term price erosion (-83% over 5 years) and bearish insider activity contrast sharply with the optimistic analyst 'strong_buy' consensus, suggesting a disconnect between fundamental performance and market expectations.

Strengths
Strong short-term liquidity with a Current Ratio of 2.75
Low leverage with a Debt/Equity ratio of 0.30
Healthy Gross Margin of 55.74% indicating a viable core product
Risks
Severe negative profitability with a Profit Margin of -40.36%
Stagnant to negative revenue growth (-1.20% YoY and -1.23% Q/Q)
Consistent earnings misses with an average surprise of -26.27% over the last 4 quarters

Compare Another Pair

OPK vs SDGR: Head-to-Head Comparison

This page compares OPKO Health, Inc. (OPK) and Schrödinger, Inc. (SDGR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile